aXichem AB
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings a… Read more
aXichem AB (AXIC-A) - Net Assets
Latest net assets as of September 2025: Skr58.07 Million SEK
Based on the latest financial reports, aXichem AB (AXIC-A) has net assets worth Skr58.07 Million SEK as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr67.76 Million) and total liabilities (Skr9.69 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr58.07 Million |
| % of Total Assets | 85.7% |
| Annual Growth Rate | 15.12% |
| 5-Year Change | 30.77% |
| 10-Year Change | 167.07% |
| Growth Volatility | 74.86 |
aXichem AB - Net Assets Trend (2008–2024)
This chart illustrates how aXichem AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for aXichem AB (2008–2024)
The table below shows the annual net assets of aXichem AB from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Skr70.16 Million | +44.58% |
| 2023-12-31 | Skr48.53 Million | +20.33% |
| 2022-12-31 | Skr40.33 Million | -28.37% |
| 2021-12-31 | Skr56.30 Million | +4.94% |
| 2020-12-31 | Skr53.65 Million | -20.11% |
| 2019-12-31 | Skr67.15 Million | +130.79% |
| 2018-12-31 | Skr29.10 Million | -14.07% |
| 2017-12-31 | Skr33.86 Million | -18.07% |
| 2016-12-31 | Skr41.33 Million | +57.33% |
| 2015-12-31 | Skr26.27 Million | +38.75% |
| 2014-12-31 | Skr18.93 Million | -24.02% |
| 2013-12-31 | Skr24.92 Million | +211.00% |
| 2012-12-31 | Skr8.01 Million | -12.24% |
| 2011-12-31 | Skr9.13 Million | +178.76% |
| 2010-12-31 | Skr3.28 Million | -42.02% |
| 2009-12-31 | Skr5.65 Million | -23.34% |
| 2008-12-31 | Skr7.37 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to aXichem AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1676465700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr11.82 Million | 16.86% |
| Other Comprehensive Income | Skr-130.32 Million | -185.82% |
| Other Components | Skr206.45 Million | 294.36% |
| Total Equity | Skr70.13 Million | 100.00% |
aXichem AB Competitors by Market Cap
The table below lists competitors of aXichem AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Antilles Gold Limited
PINK:ANTMF
|
$4.70 Million |
|
Brait SE
JSE:BAT
|
$4.70 Million |
|
Sweet Earth Holdings Corporation
PINK:SEHCF
|
$4.70 Million |
|
Mills Music Trust
PINK:MMTRS
|
$4.70 Million |
|
PT Visi Media Asia Tbk
STU:4VM
|
$4.70 Million |
|
Netcoins Holdings Inc
PINK:GARLF
|
$4.70 Million |
|
Au Gold Corp
V:AUGC
|
$4.70 Million |
|
Intrasense
PA:ALINS
|
$4.69 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in aXichem AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 48,505,000 to 70,134,000, a change of 21,629,000 (44.6%).
- Net loss of 17,813,000 reduced equity.
- New share issuances of 38,646,000 increased equity.
- Other comprehensive income decreased equity by 20,820,000.
- Other factors increased equity by 21,616,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-17.81 Million | -25.4% |
| Share Issuances | Skr38.65 Million | +55.1% |
| Other Comprehensive Income | Skr-20.82 Million | -29.69% |
| Other Changes | Skr21.62 Million | +30.82% |
| Total Change | Skr- | 44.59% |
Book Value vs Market Value Analysis
This analysis compares aXichem AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.88x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.54x to 0.88x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | Skr2.47 | Skr1.34 | x |
| 2009-12-31 | Skr1.90 | Skr1.34 | x |
| 2010-12-31 | Skr1.10 | Skr1.34 | x |
| 2011-12-31 | Skr2.83 | Skr1.34 | x |
| 2012-12-31 | Skr2.31 | Skr1.34 | x |
| 2013-12-31 | Skr5.45 | Skr1.34 | x |
| 2014-12-31 | Skr2.76 | Skr1.34 | x |
| 2015-12-31 | Skr3.28 | Skr1.34 | x |
| 2016-12-31 | Skr4.32 | Skr1.34 | x |
| 2017-12-31 | Skr2.25 | Skr1.34 | x |
| 2018-12-31 | Skr1.94 | Skr1.34 | x |
| 2019-12-31 | Skr4.08 | Skr1.34 | x |
| 2020-12-31 | Skr3.24 | Skr1.34 | x |
| 2021-12-31 | Skr3.32 | Skr1.34 | x |
| 2022-12-31 | Skr2.35 | Skr1.34 | x |
| 2023-12-31 | Skr2.39 | Skr1.34 | x |
| 2024-12-31 | Skr1.52 | Skr1.34 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently aXichem AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -25.40%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -207.85%
- • Asset Turnover: 0.12x
- • Equity Multiplier: 1.06x
- Recent ROE (-25.40%) is above the historical average (-30.07%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -14.23% | 0.00% | 0.00x | 2.15x | Skr-1.79 Million |
| 2009 | -30.35% | 0.00% | 0.00x | 2.35x | Skr-2.28 Million |
| 2010 | -72.48% | 0.00% | 0.00x | 4.50x | Skr-2.70 Million |
| 2011 | -25.82% | 0.00% | 0.00x | 2.47x | Skr-3.27 Million |
| 2012 | -43.47% | 0.00% | 0.00x | 2.17x | Skr-4.28 Million |
| 2013 | -14.67% | 0.00% | 0.00x | 1.57x | Skr-6.15 Million |
| 2014 | -29.72% | -1496.81% | 0.01x | 1.34x | Skr-7.52 Million |
| 2015 | -28.26% | 0.00% | 0.00x | 1.18x | Skr-10.05 Million |
| 2016 | -14.69% | 0.00% | 0.00x | 1.14x | Skr-10.21 Million |
| 2017 | -21.78% | 0.00% | 0.00x | 1.14x | Skr-10.76 Million |
| 2018 | -34.12% | -2885.76% | 0.01x | 1.32x | Skr-12.84 Million |
| 2019 | -18.53% | -3627.99% | 0.00x | 1.03x | Skr-19.16 Million |
| 2020 | -25.19% | -1101.47% | 0.02x | 1.04x | Skr-18.88 Million |
| 2021 | -26.81% | -346.01% | 0.07x | 1.04x | Skr-20.72 Million |
| 2022 | -42.82% | -344.72% | 0.08x | 1.52x | Skr-21.29 Million |
| 2023 | -42.90% | -1150.41% | 0.03x | 1.27x | Skr-25.66 Million |
| 2024 | -25.40% | -207.85% | 0.12x | 1.06x | Skr-24.83 Million |
Industry Comparison
This section compares aXichem AB's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $187,485,753
- Average return on equity (ROE) among peers: -50.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| aXichem AB (AXIC-A) | Skr58.07 Million | -14.23% | 0.17x | $4.70 Million |
| Svenska Aerogel Holding AB (publ) (AERO) | $52.02 Million | -76.93% | 0.76x | $1.21 Million |
| Arla Plast AB (ARPL) | $389.45 Million | 20.58% | 0.48x | $36.28 Million |
| I-Tech (ITECH) | $116.03 Million | 9.15% | 0.08x | $41.86 Million |
| KB Components AB (publ) (KBC) | $600.79 Million | 16.50% | 2.73x | $110.94 Million |
| Nexam Chemical Holding AB (NEXAM) | $183.31 Million | -4.91% | 0.26x | $16.50 Million |
| Organoclick AB (ORGC) | $13.29 Million | -60.10% | 0.52x | $4.39 Million |
| Photocat AS (PCAT) | $11.30 Million | -19.11% | 0.63x | $2.25K |
| Polygiene AB (POLYG) | $319.61 Million | 5.27% | 0.10x | $6.01 Million |
| Triboron International AB (publ) (TRIBO-B) | $1.57 Million | -346.46% | 1.18x | $1.87 Million |